PMGC Holdings Inc. (NASDAQ:ELAB – Free Report) shares are scheduled to reverse split on Tuesday, March 10th. The 1-6 reverse split was announced on Wednesday, March 4th. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, March 9th.
PMGC Stock Down 32.8%
Shares of ELAB opened at $0.71 on Friday. The company has a 50-day simple moving average of $3.06 and a 200-day simple moving average of $14.84. The company has a market capitalization of $2.29 million, a PE ratio of -0.01 and a beta of 1.12. PMGC has a 52-week low of $0.68 and a 52-week high of $114.38.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of PMGC in a research report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.
PMGC Company Profile
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.
Read More
- Five stocks we like better than PMGC
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.
